These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29309395)

  • 1. The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease.
    Ozturk K; Dogan T; Celikkanat S; Ozen A; Demirci H; Kurt O; Turker T; Yilmaz Y; Uygun A
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):411-417. PubMed ID: 29309395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
    Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
    Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
    Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
    BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease.
    Dogan T; Ozturk K; Celikkanat S; Aykan MB; Uygun A
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1460-1466. PubMed ID: 31045630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score.
    Xin Z; Zhu Y; Wang S; Liu S; Xu M; Wang T; Lu J; Chen Y; Zhao Z; Wang W; Ning G; Bi Y; Xu Y; Li M
    Liver Int; 2020 Apr; 40(4):806-814. PubMed ID: 31820847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease.
    Arai T; Atsukawa M; Tsubota A; Kato K; Abe H; Ono H; Kawano T; Yoshida Y; Tanabe T; Okubo T; Hayama K; Nakagawa-Iwashita A; Itokawa N; Kondo C; Kaneko K; Emoto N; Nagao M; Inagaki K; Fukuda I; Sugihara H; Iwakiri K
    Sci Rep; 2021 Aug; 11(1):15938. PubMed ID: 34354193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial stiffness is increased in nondiabetic, nonhypertensive postmenopausal women with nonalcoholic fatty liver disease.
    Li X; Shi H; Wang Z; Chang L; Zhang M; Dong X
    J Hypertens; 2017 Jun; 35(6):1226-1234. PubMed ID: 28441694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population.
    Taharboucht S; Guermaz R; Brouri M; Chibane A
    J Med Vasc; 2021 May; 46(3):129-138. PubMed ID: 33990287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease.
    Yari FA; Shabani P; Karami S; Sarmadi N; Poustchi H; Bandegi AR
    BMC Endocr Disord; 2021 Aug; 21(1):153. PubMed ID: 34344333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
    Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease.
    Colak Y; Karabay CY; Tuncer I; Kocabay G; Kalayci A; Senates E; Ozturk O; Doganay HL; Enc FY; Ulasoglu C; Kiziltas S
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):613-8. PubMed ID: 22495402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of subclinical carotid artery atherosclerosis assessed by carotid ultrasound with nonalcoholic fatty liver disease fibrosis score in young and middle-aged men.
    Durak H; Çetin M; Emlek N; Özyıldız AG; Ergül E; Duman H
    Int J Cardiovasc Imaging; 2024 Sep; 40(9):1979-1986. PubMed ID: 39012403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.
    Gill C; Vatcheva KP; Pan JJ; Smulevitz B; McPherson DD; Fallon M; McCormick JB; Fisher-Hoch SP; Laing ST
    Am J Cardiol; 2017 Jun; 119(11):1717-1722. PubMed ID: 28395890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Dogru T; Genc H; Tapan S; Aslan F; Ercin CN; Ors F; Kara M; Sertoglu E; Karslioglu Y; Bagci S; Kurt I; Sonmez A
    Clin Endocrinol (Oxf); 2013 May; 78(5):712-7. PubMed ID: 22676641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity.
    Puig J; Blasco G; Daunis-I-Estadella J; Loshuertos E; Codina J; Cuba V; Ortiz R; Xifra G; Ricart W; Pedraza S; Federici M; Fernández-Real JM
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):180-6. PubMed ID: 25510350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease.
    Kucukazman M; Ata N; Yavuz B; Dal K; Sen O; Deveci OS; Agladioglu K; Yeniova AO; Nazligul Y; Ertugrul DT
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):147-51. PubMed ID: 23085576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis.
    Başar O; Akbal E; Köklü S; Tuna Y; Koçak E; Başar N; Tok D; Erbiş H; Senes M
    Herz; 2013 Jun; 38(4):417-22. PubMed ID: 23324907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation between carotid intima media thickness and serum osteoprotegerin levels in nonalcoholic fatty liver disease.
    Ayaz T; Kirbas A; Durakoglugil T; Durakoglugil ME; Sahin SB; Sahin OZ; Kirvar A; Tasci F
    Metab Syndr Relat Disord; 2014 Jun; 12(5):283-9. PubMed ID: 24689950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.
    Bhatia L; Scorletti E; Curzen N; Clough GF; Calder PC; Byrne CD
    Atherosclerosis; 2016 Mar; 246():13-20. PubMed ID: 26748347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.